Where I see patients (4)
The Cancer Moonshot Immuno-Oncology Translational Network (IOTN) at age 5: Accelerating Cancer Immunotherapies.
Journal of the National Cancer Institute
CD4+ T cells help myeloid-mediated killing of immune-evasive tumors.
Trends in cancer
Biomarker-directed, pembrolizumab-based combination therapy in non-small cell lung cancer: phase 2 KEYNOTE-495/KeyImPaCT trial interim results.
Vactosertib With Durvalumab in Urothelial Carcinoma Failing Checkpoint Inhibition
ORR by RECIST version 1.1
A Study of AMG 340 in Subjects With Metastatic Castrate-Resistant Prostate Carcinoma
An Open-Label Dose-Escalation Study to Evaluate XmAb24306 as a Single Agent and in Combination ...
Neoadjuvant Atezolizumab-Based Combination Therapy in Men With Localized Prostate Cancer Prior ...
A positive response is defined as a ≥40% increase in the number of infiltrating cluster of differentiation 3 (CD3) + T cells between the pre-treatment biopsy at baseline and the post-treatment RP specimen. Thus, a negative respons...